COMMONWEALTH EQUITY SERVICES, LLC - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 12 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q3 2022$8,000
-20.0%
11,0000.0%0.00%
Q2 2022$10,0000.0%11,0000.0%0.00%
Q1 2022$10,0000.0%11,0000.0%0.00%
Q4 2021$10,0000.0%11,0000.0%0.00%
Q3 2021$10,0000.0%11,0000.0%0.00%
Q2 2021$10,0000.0%11,0000.0%0.00%
Q1 2021$10,0000.0%11,0000.0%0.00%
Q4 2020$10,0000.0%11,0000.0%0.00%
Q3 2020$10,0000.0%11,0000.0%0.00%
Q2 2020$10,0000.0%11,0000.0%0.00%
Q1 2020$10,0000.0%11,0000.0%0.00%
Q4 2019$10,000
+11.1%
11,0000.0%0.00%
Q3 2019$9,000
-10.0%
11,0000.0%0.00%
Q2 2019$10,0000.0%11,0000.0%0.00%
Q1 2019$10,000
+11.1%
11,0000.0%0.00%
Q4 2018$9,000
-10.0%
11,0000.0%0.00%
Q3 2018$10,000
-37.5%
11,000
-35.3%
0.00%
Q2 2018$16,000
+14.3%
17,0000.0%0.00%
Q1 2018$14,000
-6.7%
17,0000.0%0.00%
Q4 2017$15,00017,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q1 2021
NameSharesValueWeighting ↓
Southpaw Asset Management LP 20,000,000$17,675,00025.38%
INCOME RESEARCH & MANAGEMENT 23,109,000$20,278,0005.29%
Fore Capital, LLC 5,000,000$4,430,0001.71%
RIVERHEAD CAPITAL MANAGEMENT LLC 20,000,000$17,603,0000.74%
ARISTEIA CAPITAL, L.L.C. 18,500,000$16,361,0000.70%
ZAZOVE ASSOCIATES LLC 11,153,000$9,843,0000.58%
BASSO CAPITAL MANAGEMENT, L.P. 3,600,000$3,182,0000.52%
CSS LLC/IL 10,450,000$9,240,0000.45%
Lombard Odier Asset Management (Europe) Ltd 7,950,000$7,038,0000.44%
Wellesley Asset Management 6,740$5,948,0000.31%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders